Article Details

Landos Biopharma Announces FDA Clearance of IND Application for Omilancor for the Treatment ...

Retrieved on: 2021-04-07 10:41:15

Tags for this article:

Click the tags to see associated articles and topics

Landos Biopharma Announces FDA Clearance of IND Application for Omilancor for the Treatment .... View article details on hiswai:

Excerpt

BLACKSBURG, VA, USA I April 06, 2021 I Landos Biopharma (NASDAQ: LABP), a clinical-stage biopharmaceutical company focused on the ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up